Aarti Drugs Ltd.

NSE: AARTIDRUGS  SECTOR: Pharmaceuticals & Drugs

1273.55
+11.75 (0.93%)

Price Summary

Today's High

₹ 1291

Today's Low

₹ 1200

52 Week High

₹ 1308

52 Week Low

₹ 419.3

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.

Company Essentials

Market Cap

2967.3715 Cr.

Enterprise Value

3433.0367 Cr.

No. of Shares

2.33 Cr.

P/E

21.87

P/B

4.77

Face Value

₹ 10

Div. Yield

0.16%

Book Value (TTM)

₹  266.8627

CASH

4.8479 Cr.

DEBT

470.5131 Cr.

Promoter Holding

61.44%

EPS (TTM)

₹  58.2275

Sales Growth

27.514920326718%

ROE

18.3363719502457 %

ROCE

17.3907756858605 %

Profit Growth

6.00019831479186 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1w1m3m6m1Yr3Yr5Yr

* Prices are based on daily market changes.

Valuation Chart 1w1m3m6m1Yr3Yr5Yr

* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Sales Growth (in Cr.)

1 Year27.51%
3 Year10.58%
5 Year8.4%

Profit Growth (in Cr.)

1 Year18.86%
3 Year9.6%
5 Year7.17%

ROE%

1 Year18.34%
3 Year18.9%
5 Year20.99%

ROCE %

1 Year17.39%
3 Year17.35%
5 Year18.26%

Debt/Equity

0.907316838946007

Price to Cash Flow

20.15

Interest Cover Ratio

4.11254027134534

CFO/PAT (5 Yr. Avg.)

1.62177373580718

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2020 61.44 0
Dec 2019 61.62 0
Sep 2019 61.64 0
Jun 2019 62.25 0
Mar 2019 62.26 0
* Figures given above are % of equity capital

 Strengths

  • The company has a good cash flow management; CFO/PAT stands at 1.62177373580718.
  • The company has a high promoter holding of 61.44%.

 Limitations

  • The company has shown a poor profit growth of 9.59631626312962% for the Past 3 years.
  • The company has shown a poor revenue growth of 10.5801521923519% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020
Net Sales 432.54 370.02 442.71 415.61 406.57
Total Expenditure 380.05 317.72 377.49 356.31 338.97
Operating Profit 52.49 52.3 65.22 59.3 67.6
Other Income 5.03 0.1 0.21 0.13 0.61
Interest 9.73 8.79 8.08 8.08 7.24
Depreciation 10.28 11.29 11.55 11.85 11.99
Exceptional Items 0 0 0 0 8.38
Profit Before Tax 37.51 32.32 45.8 39.51 57.36
Tax 11.82 10.75 15 12.75 0.8
Profit After Tax 25.69 21.57 30.8 26.76 56.56
Adjusted EPS (Rs) 1.09 0.93 1.32 1.15 2.43

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Net Sales 1087.22 1075.5 1088.72 1140.46 1454.25
Total Expenditure 914.93 899.74 909.74 955.32 1251.51
Operating Profit 172.29 175.76 178.98 185.13 202.74
Other Income 0.65 0 3.53 1.17 6.28
Interest 42.21 47.34 38.05 36.3 41
Depreciation 30.66 35.58 36.69 37.8 40.39
Exceptional Items 0 0 0 0 0
Profit Before Tax 100.06 92.84 107.78 112.21 127.62
Tax 22.47 26.55 32.3 38.8 40.37
Net Profit 77.6 66.29 75.48 73.41 87.26
Adjusted EPS (Rs.) 32.04 27.37 31.64 31.13 37

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Equity and Liabilities
Share Capital 24.22 24.22 23.86 23.58 23.58
Total Reserves 279.49 326.1 363.11 409.59 494.99
Borrowings 151.47 175.21 187.45 186.16 195.26
Other N/C liabilities 47.35 52.1 92.53 108.18 119.03
Current liabilities 464.4 477.08 449.18 588.74 547.36
Total Liabilities 966.93 1054.7 1116.12 1316.24 1380.23
Assets
Net Block 431.48 462.77 542.32 563.59 585.67
Capital WIP 13.35 34.04 14.13 27.99 32.37
Investments 11.11 11.12 18.42 17.24 18.92
Loans & Advances 4.24 4.74 11.76 10.77 8.27
Other N/C Assets 0 0 0 0 0
Current Assets 506.74 542.03 529.48 696.65 735
Total Assets 966.93 1054.7 1116.12 1316.24 1380.23
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Profit Before Tax 100.06 92.84 107.78 112.21 127.62
Adjustment 68.73 78.2 68.2 71.06 70.26
Working Capital Changes -47.03 -25.75 17.93 -99.42 -21.68
Tax Paid -14.94 -20.02 -19.51 -21.92 -28.91
Operating Cash Flow 106.83 125.27 174.41 61.93 147.3
Investing Cash Flow -102.3 -87.4 -96.29 -71.09 -59.33
Financing Cash Flow -5.49 -36.79 -78.42 9.12 -86.96
Net Cash Flow -0.97 1.07 -0.31 -0.04 1.01

Corporate Actions

Ratings & Research Reports

Company Presentations

Company News

Aarti Drugs Stock Price Analysis and Quick Research Report. Is Aarti Drugs an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Aarti Drugs and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 147.2975 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Aarti Drugs has a Debt to Equity ratio of 0.907316838946007 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Aarti Drugs , the EPS growth was 18.8632416343711 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Aarti Drugs has OPM of 13.9414129695123 % which is a bad sign for profitability.
     
  • ROE: Aarti Drugs have a average ROE of 18.3363719502457 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Aarti Drugs

X